AAP Issues Updated Guidance on Palivizumab Prophylaxis for RSV Infection - Practice ...
Dec 15, 2014 - The American Academy of Pediatrics (AAP) Committee on Infectious Diseases has updated its guidance on the use of palivizumab (Synagis) prophylaxis in infants and children at increased risk of respiratory syncytial virus (RSV) infection. Because the palivizumab package labeling does not ...
American Family Physician : Practice Guidelines
https://www.aafp.org/afp/2014/1215/p867.html
navigate_before 1 navigate_next